Search research articles
Contact Us
Filters
Showing results (11-20 of 31) with videos related to
Page
of 4
Sort By:
BJU International
|
August 3, 2007
Genetic impact on prostate anatomical variability during ageing: role of CYP17, SRD5A2 and androgen receptor genes polymorphisms
Stéphane Larré, Hikmat Hamadeh, Abdel Rahmene Azzouzi, et al.
Journal of the American Society of Cytopathology
|
July 12, 2023
The 2023 Bethesda System for reporting thyroid cytopathology
Syed Z Ali, Zubair W Baloch, Beatrix Cochand-Priollet, et al.
Thyroid : Official Journal of the American Thyroid Association
|
July 10, 2023
The 2023 Bethesda System for Reporting Thyroid Cytopathology
Syed Z Ali, Zubair W Baloch, Beatrix Cochand-Priollet, et al.
Diagnostic Cytopathology
|
October 3, 2002
Cost of screening for cancerous and precancerous lesions of the cervix
Estelle Méréa, Catherine Le Galès, Beatrix Cochand-Priollet, et al.
Human Pathology
|
April 16, 2017
Clusterin expression in medullary thyroid carcinoma is inversely correlated with the presence of lymph node metastases
Najat Mourra, Malika Bennis, Pierre-Yves Boelle, et al.
JBMR Plus
|
April 7, 2026
A rare coexistence: Ollier disease and primary hyperparathyroidism-mere coincidence or expanding the spectrum of Ollier disease?
Justine Luciano, Astrid Dauchez, Beatrix Cochand-Priollet, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 7, 2023
FCH-PET/CT in Primary Hyperparathyroidism With Discordant/Negative MIBI Scintigraphy and Ultrasonography
Eugenie Koumakis, Mathieu Gauthé, Alessandro Martinino, et al.
World Journal of Surgery
|
July 19, 2020
<sup>18</sup>F-fluorocholine PET/CT in MEN1 Patients with Primary Hyperparathyroidism
Mathieu Gauthé, Anne Dierick-Gallet, Thierry Delbot, et al.
Plos One
|
September 15, 2017
DUSP5 and DUSP6, two ERK specific phosphatases, are markers of a higher MAPK signaling activation in BRAF mutated thyroid cancers
Camille Buffet, Karine Hecale-Perlemoine, Léopoldine Bricaire, et al.
Diagnostic Cytopathology
|
May 15, 2008
Post-thyroid FNA testing and treatment options: a synopsis of the National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference
Lester J Layfield, Jacki Abrams, Beatrix Cochand-Priollet, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 31) with videos related to
Sort By:
Page
of 4
BJU International
|
August 3, 2007
Genetic impact on prostate anatomical variability during ageing: role of CYP17, SRD5A2 and androgen receptor genes polymorphisms
Stéphane Larré, Hikmat Hamadeh, Abdel Rahmene Azzouzi, et al.
Journal of the American Society of Cytopathology
|
July 12, 2023
The 2023 Bethesda System for reporting thyroid cytopathology
Syed Z Ali, Zubair W Baloch, Beatrix Cochand-Priollet, et al.
Thyroid : Official Journal of the American Thyroid Association
|
July 10, 2023
The 2023 Bethesda System for Reporting Thyroid Cytopathology
Syed Z Ali, Zubair W Baloch, Beatrix Cochand-Priollet, et al.
Diagnostic Cytopathology
|
October 3, 2002
Cost of screening for cancerous and precancerous lesions of the cervix
Estelle Méréa, Catherine Le Galès, Beatrix Cochand-Priollet, et al.
Human Pathology
|
April 16, 2017
Clusterin expression in medullary thyroid carcinoma is inversely correlated with the presence of lymph node metastases
Najat Mourra, Malika Bennis, Pierre-Yves Boelle, et al.
JBMR Plus
|
April 7, 2026
A rare coexistence: Ollier disease and primary hyperparathyroidism-mere coincidence or expanding the spectrum of Ollier disease?
Justine Luciano, Astrid Dauchez, Beatrix Cochand-Priollet, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 7, 2023
FCH-PET/CT in Primary Hyperparathyroidism With Discordant/Negative MIBI Scintigraphy and Ultrasonography
Eugenie Koumakis, Mathieu Gauthé, Alessandro Martinino, et al.
World Journal of Surgery
|
July 19, 2020
<sup>18</sup>F-fluorocholine PET/CT in MEN1 Patients with Primary Hyperparathyroidism
Mathieu Gauthé, Anne Dierick-Gallet, Thierry Delbot, et al.
Plos One
|
September 15, 2017
DUSP5 and DUSP6, two ERK specific phosphatases, are markers of a higher MAPK signaling activation in BRAF mutated thyroid cancers
Camille Buffet, Karine Hecale-Perlemoine, Léopoldine Bricaire, et al.
Diagnostic Cytopathology
|
May 15, 2008
Post-thyroid FNA testing and treatment options: a synopsis of the National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference
Lester J Layfield, Jacki Abrams, Beatrix Cochand-Priollet, et al.
Page
of 4